Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Covidien Ltd. (COV)
Financials 
Technical Analysis 0
TOP PICK
Makes products that you need in hospitals that are very low margin, high-volume, e.g. Like syringes. A serial acquirer. Has a DRIP program. This will continue to grow.
Darren SissonsOwned
biotechnologypharmaceutical
TOP PICK
Medical instruments. Most of its products are in the operating room. Also have a generic drug division which they will be spinning off in the next year or two. The value of the 2 when separated will be more than what the current price is. Earnings have been growing very nicely. Will also be doing a buy back.
Norman LevineOwned
biotechnologypharmaceutical
TOP PICK
Medical devices. Its products are largely in the operating room. As the US economy is doing better, operations are picking up. Located in Ireland for tax reasons. Also have a pharma business which they are planning on spinning out in the next year or so. The some of the 2 parts is more than what the company is trading at right now. 1.7% dividend and are planning on doing share buybacks.
Norman LevineOwned
biotechnologypharmaceutical
TOP PICK
US company but incorporated in Ireland for tax reasons. That has been hurting the stock as people think it is an Irish/European company. Supplies operating rooms with items that have to be replaced quite often. Good price.
Norman LevineOwned
biotechnologypharmaceutical
PAST TOP PICK
(Top Pick Nov 9/10, Up 2.74%) Thinks they will sell their generic drug manufacturing business at some point. Whole hospital business was hit because people are delaying operations in the US. They can’t put them off indefinitely. High profit margin business.
Norman LevineOwned
biotechnologypharmaceutical
TOP PICK
(A Top Pick Oct 6/10. Up 12.64%.) Main products are the small medical devices used in OR’s. Got hurt in the recession when people lost health care benefits and stopped having operations. This is starting to pick up a little bit. Sees organic and market share growth. Also have a generic pharmaceutical division that he believes they want to spin out or sell. Yield of about 2.5%.
Norman LevineOwned
biotechnologypharmaceutical
TOP PICK
Medical devices for ORs, pharmaceuticals and medical supplies. Based in Ireland. Stock was hurt with the Tylenol recall and a drop in surgeries with the drop in the economy. That is now stabilizing.
Norman LevineOwned
biotechnologypharmaceutical
Showing 16 to 25 of 25 entries
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
